Luca Melchiori: An In-Depth Investigation of CD36 Blockade in Human Macrophage and In Vivo Tumour Models
Luca Melchiori/LinkedIn

Luca Melchiori: An In-Depth Investigation of CD36 Blockade in Human Macrophage and In Vivo Tumour Models

Luca Melchiori, Senior Director, Global Product Leader Immunology R&D at AstraZeneca, shared on LinkedIn:

“CD36 is the focus of many therapeutics in development that aim at blocking lipid uptake by immune cells in the TME and prevent/revert immunosuppression.

In this manuscript we describe an in depth investigation of CD36 blockade, in both multiple primary human macrophages models and several syngeneic in vivo tumor models, with specific focus to tissue distribution and specifity using commercially available anti-CD36 mAbs.

We found that while CD36 is an effective transporter of oxidized LDL, selective CD36-blockade fails to rewire suppressive macrophages towards a pro-inflammatory phenotype, resulting in lack of anti-tumour activity in multiple mouse models. We speculate that this likely results from the redundancy of many receptors of macrophages involved in lipid uptake. A cautionary tale if your aim is to target lipid metabolism in the TME.

A big shout to the star of my ex-team Lizzie Kuczynski, the incredibly dedicated Kyoko Nakamura, the promising young scientist Borjan V. and all the authors that worked hard to get this important piece of science published.”

Title: Minimal functional activity and presence of an antigen sink limit CD36 blockade as a macrophage-targeted cancer immunotherapy

Authors: Elizabeth Kuczynski, Kyoko Nakamura, Gareth Browne, Andrea Gonzalez-Munoz, Francesca Delvecchio, Jane Coates-Ulrichsen, Mukul Tewary, Borjan Venovski, Jessica Dawson, Shreya Ahuja, Grace Opoku-Ansah, Amanda Watkins, Lorraine Irving, Tilbe Creigh-Pulatmen, Pablo Morentin Gutierrez, Jessie Salter, Rebecca Dudley, Mathilde Colombe, Allison Gerber, Kelli Ryan, Kathy Mulgrew, Sonja Hess, Matt Glover, Francisca Wollerton, Robert W. Wilkinson, Elina Timosenko, Alan Sandercock, Mark Cobbold, Simon J. Dovedi, Luca Melchiori

Read the Full Article on PLOS.